Skip to main content

Hepatic malignancies in childhood and adolescence (hepatoblastoma, hepatocellular carcinoma, and embryonal sarcoma)

  • Chapter
Diagnostic and Therapeutic Advances in Pediatric Oncology

Part of the book series: Cancer Treatment and Research ((CTAR,volume 92))

Abstract

Primary malignant liver tumors are uncommon in pediatric patients. Hepatoblastoma, hepatocellular carcinoma, and embryonal sarcoma are the primary entities that challenge the pediatric oncologist. Although these tumors are potentially curable, the efficacy of treatment is highly dependent on anatomic location and responsiveness to chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Iwama T, Mishima Y. 1994. Mortality in young first-degree relatives of patients with familial adenomatous polyposis. Cancer 73:2065–2068.

    Article  PubMed  CAS  Google Scholar 

  2. Li FP, Thurber WA, Seddon J, et al. 1987. Hepatoblastoma in families with polyposis coli. JAMA 257:2475–2477.

    Article  PubMed  CAS  Google Scholar 

  3. Garber JE, Li FP. Kingston JE, et al. 1988. Hepatoblastoma and familial adenomatous polyposis. J Natl Cancer Inst 80:1626–1628.

    Article  PubMed  CAS  Google Scholar 

  4. Simms LA, Reeve AE, Smith PJ. 1995. Genetic mosaicism at the insulin locus in liver associated with childhood hepatoblastoma. Genes Chromosomes Cancer 13:72–73.

    Article  PubMed  CAS  Google Scholar 

  5. Rainier S, Dobry CJ, Feinberg AP. 1995. Loss of imprinting in hepatoblastoma. Cancer Res 55:1836–1838.

    PubMed  CAS  Google Scholar 

  6. Albrecht S, von Schweinitz D, Waha A, et al. 1994. Loss of maternal alleles on chromosome arm 11p in hepatoblastoma. Cancer Res 54:5041–5044.

    PubMed  CAS  Google Scholar 

  7. Mascarello JT, Jones MC, Kadota RP, et al. 1990. Hepatoblastoma characterized by trisomy 20 and double minutes. Cancer Genet Cytogenet 47:243–247.

    Article  PubMed  CAS  Google Scholar 

  8. Fletcher JA, Kozakewich HP, Pavelka K, et al. 1991. Consistent cytogenetic aberrations in hepatoblastoma: a common pathway of genetic alterations in embryonal liver and skeletal muscle malignancies? Genes Chromosomes Cancer 3:34–43.

    Article  Google Scholar 

  9. Schneider NR, Cooley LD, Finegold MJ, et al. In press. Report of the first recurring chromosome translocation in hepatoblastoma: der(4)l(l;4)(q12;q34). Genes Chromosomes Cancer. 19:291–294, 1977.

    Article  Google Scholar 

  10. Hansen K, Bagtas J, Mark HF, et al. 1992. Undifferentiated small cell hepatoblastoma with aunique chromosomal translocation: a case report. Pediatr Pathol 12:457–462.

    Article  PubMed  CAS  Google Scholar 

  11. Buckley JD, Sather H, Ruccione K, et al. 1989. A case—control study of risk factors for hepatoblastoma. Cancer 64:1169–1176.

    Article  PubMed  CAS  Google Scholar 

  12. Weinberg AG, Finegold MJ. 1983. Primary hepatic tumors of childhood. Hum Pathol 14:512–537.

    Article  PubMed  CAS  Google Scholar 

  13. Conran RM, Hitchcock CL, Waclawiw MA, et al. 1992. Hepatoblastoma: the prognostic significance of histologic type. Pediatr Pathol 12:167–183.

    Article  PubMed  CAS  Google Scholar 

  14. Dehner LP, Manivel JC. 1988. Hepatoblastoma: an analysis of the relationship between morphologic subtypes and prognosis. Am J Pediatr Hematol Oncol 10:310–307.

    Google Scholar 

  15. von Schweinitz D, Wischmeyer P. Leuschner I, et al. 1994. Clinico-pathological criteria with prognostic relevance in hepatoblastoma. Eur J Cancer 30A: 1052–1058.

    Article  Google Scholar 

  16. Haas JE, Muczynski KA, Krailo M, et al. 1989. Histopathology and prognosis in childhood hepatoblastoma and hepalocarcinoma. Cancer 64:1082–1095.

    Article  PubMed  CAS  Google Scholar 

  17. Lack EE, Neave C, Vawter GF. 1982. Hepatoblastoma: a clinical and pathologic study of 54 cases. Am J Surg Pathol 6:693–705.

    Article  PubMed  CAS  Google Scholar 

  18. King SJ, Babyn PS, Greenberg ML, et al. 1992. Value of CT in determining the resectability of hepatoblastoma before and after chemotherapy. Am J Roentgen 160:793–798.

    Google Scholar 

  19. Archer D, Babyn P, Gilday D, et al. 1993. Potentially misleading bone scan fmdigns in patients with hepatoblastoma. Clin Nucl Med 18:1026–1031.

    Article  PubMed  CAS  Google Scholar 

  20. Mackinlay GA, Pritchard J. 1992. A common language for childhood liver tumours. Pediatr Surg Int 7:325–326.

    Article  Google Scholar 

  21. Tan C, Rosen G, Ghavimi F, et al. 1975. Adriamycin (NSC-123127) in pediatric malignancies. Cancer Chemother Rep 6:259–266.

    Google Scholar 

  22. Andrassy RJ, Brennan LP, Siegel MM, et al. 1980. Preoperative chemotherapy for hepatoblastoma in children: report of six cases. J Pediatr Surg 15:517–522.

    Article  PubMed  CAS  Google Scholar 

  23. Weinblatt ME, Siegel SE, Siegel MM, et al. 1982. Preoperative chemotherapy for unresectable primary hepatic malignancies in children. Cancer 50:11061–11064.

    Article  Google Scholar 

  24. Quinn JJ, Altman AJ, Robinson HT, et al. 1985. Adriamycin and cisplatin for hepatoblastoma. Cancer 56:1926–1929.

    Article  PubMed  CAS  Google Scholar 

  25. Douglass EC, Green AA, Wrenn E, et al. 1985. Effective cisplatin (DDP) based chemotherapy in the treatment of hepatoblastoma. Med Pediatr Oncol 13:187–190.

    Article  PubMed  CAS  Google Scholar 

  26. Douglass EC, Green AA, Priest JR, et al. 1987. Effective therapy for metastatic/unresectable hepatoblastoma (HB) (abstract). Proc Am Soc Clin Oncol 6:214.

    Google Scholar 

  27. Black CT, Cangir A, Choroszy M, et al. 1991. Marked response to preoperative high-dose cis-platinum in children with unresectable hepatoblastoma. J Pediatr Surg 26:1070–1073.

    Article  PubMed  CAS  Google Scholar 

  28. Evans A, Land VJ, Newton WA, et al. 1982. Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, and 5-fluorouracil) in the treatment of children with malignant hepatoma. Cancer 50:821–826.

    Article  PubMed  CAS  Google Scholar 

  29. Ortega JA, Krailo MD, Haas JE, et al. 1991. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Children’s Cancer Study Group. J Clin Oncol 9:2167–2176.

    PubMed  CAS  Google Scholar 

  30. Douglass EC, Reynolds M, Finegold M. et al. 1993. Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group Study. J Clin Oncol 11:96–99.

    PubMed  CAS  Google Scholar 

  31. Ortega JA, Douglass E, Feusner J. et al. 1994. A randomized trial of cisplatin/vincristine/5-fluorouracil vs. cisplatin/doxorubicin i.v. continuous infusion for the treatment of hepatoblastoma. Results from the Pediatric Intergroup Hepatoma Study (CCG-8881/POG 9845) (abstract). Proc Am Soc Clin Oncol 13:416.

    Google Scholar 

  32. Ortega JA, Douglass EC, Fcusner J, et al. In press. A randomized of trial of cisplatin/ vincrisline/5-fluorouracil vs. cisplatin/adriamycin I.V. continuous infusion for the treatment of hepatoblastoma: a report from the Pediatric Liver Tumor Intergroup (CCG 8881/POG 8945). J Clin Oncol.

    Google Scholar 

  33. Perilongo G, Plaschkes J, Brown J, et al. 1996. Response of hepatoblastoma to pre-operative chemotherapy with cisplatin and doxorubicin (PLADO) in the International Society of Paediatric Oncology Liver tumor Study (abstract). Proc Am Soc Clin Oncol 14:444.

    Google Scholar 

  34. von Schweinitz D, Hecker H, Harms D. et al. 1995. Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma: a report from the German Cooperative Pediatric Liver tumor Study HB-89. J Pediatr Surg 30:845–852.

    Article  Google Scholar 

  35. Feusner JH, Krailo MD, Haas JE, et al. 1993. Treatment of pulmonary metastases of initial stage I hepatoblastoma in childhood: report from the Children’s Cancer Group. Cancer 71:859–864.

    Article  PubMed  CAS  Google Scholar 

  36. Black CT, Luck SR, Musemeche CA, et al. 1991. Aggressive excision of pulmonary metastases is warranted in the management of childhood hepatic tumors. J Pediatr Surg 26:1082–1085.

    Article  PubMed  CAS  Google Scholar 

  37. Passmore SJ, Noblett HR, Wisheart JD, et al. 1995. Prolonged survival following multiple thoracotomies for metastatic hepatoblastoma. Med Pediatr Oncol 24:58–60.

    Article  PubMed  CAS  Google Scholar 

  38. Habrand J-L, Nehme D. Kalifa C, et al. 1992. Is there a place for radiation therapy in the management of hepatoblastomas and hepatocellular carcinomas in children? (Abstract.) Int J Radiat Oncol Biol Phys 23:525–531.

    Article  PubMed  CAS  Google Scholar 

  39. Kovalic JJ, Thomas PRM, Beckwith JB, et al. 1991. Hepatocellular carcinoma as second malignant neoplasms in successfully treated Wilms’ tumor patients. Cancer 67:342–344.

    Article  PubMed  CAS  Google Scholar 

  40. Lack EE, Neave C, Vawter GF. 1983. Hepatocellular carcinoma: review of 32 cases in childhood and adolescence. Cancer 52:1510–1515.

    Article  PubMed  CAS  Google Scholar 

  41. Farmer DG, Busuttil RW. 1994. The role of multimodal therapy in the treatment of hepato-cellular carcinoma. Cancer 73:2669–2670.

    Article  PubMed  CAS  Google Scholar 

  42. Douglass E. Ortega J, Feusner J. et al. 1994. Hepatocellular carcinoma in children and adolescents: Results from the Pediatric Integroup Hepatoma Study (CCG 8881/POG 8945) (abstract). Proc Am Soc Clin Oncol 13:420.

    Google Scholar 

  43. Venook AP. 1994. Treatment of hepatocellular carcinoma: too many options? J Clin Oncol 12:1323–1334.

    PubMed  CAS  Google Scholar 

  44. Ringe B, Wittekind C, Bechstein WO, et al. 1989. The role of liver transplantation in hepatobiliary malignancy. Ann Surg 209:88–98.

    Article  PubMed  CAS  Google Scholar 

  45. Olthoff KM, Millis JM. Rosove MH, et al. 1990. Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg 125:1261–1268.

    Article  PubMed  CAS  Google Scholar 

  46. Iwatsuki S, Starzl TE, Sheahan DG, et al. 1991. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 214:221–229.

    Article  PubMed  CAS  Google Scholar 

  47. Penn J. 1991. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 110:726–734.

    PubMed  CAS  Google Scholar 

  48. Koneru B, Flye MW, Busuttil RW, et al. 1991. Liver transplantation for hepatoblastoma: the American experience. Ann Surg 213:118–121.

    Article  PubMed  CAS  Google Scholar 

  49. Tagge EP, Tagge DU, Reyes J, et al. 1992. Resection including transplantation, for hepatoblastoma and hepatocellular carcinoma: impact on survival. J Pediatr Surg 27:292–297.

    Article  PubMed  CAS  Google Scholar 

  50. Esquivel CO, Gutierrez C, Cox KL, et al. 1994. Hepatocellular carcinoma and liver cell dysplasia in children with chronic liver disease. J Pediatr Surg 11:1465–1469.

    Article  Google Scholar 

  51. Stocker JT, Ishak KG. 1978. Undifferentiated (embryonal) sarcoma of the liver: report of 31 cases. Cancer 42:336–348.

    Article  PubMed  CAS  Google Scholar 

  52. Parham DM, Kelly DR, Donnelly WH, et al. 1991. The immunohistochemical and ultrastructural spectrum of hepatic sarcomas of childhood: evidence for a common histogenesis. Mod Pathol 4:648–653.

    PubMed  CAS  Google Scholar 

  53. de Chadarevian J-P, Pawel BR, Faerber EN, et al. 1994. Undifferentiated (embryonal) sarcoma arising in conjunction with mesenchymal hamartoma of the liver. Mod Pathol 7:490–493.

    PubMed  Google Scholar 

  54. Leuschner I, Schmidt D, Harms D. 1990. Undifferentiated sarcoma of the liver in childhood. Hum Pathol 21:68–76.

    Article  PubMed  CAS  Google Scholar 

  55. Horowitz ME, Etcubanas E, Webber BL, et al. 1987. Hepatic undifferentiated (embryonal) sarcoma and rhabdomyosarcoma in children: results of therapy. Cancer 59:396–402.

    Article  PubMed  CAS  Google Scholar 

  56. Babin-Boilletot A, Flamant F, Lacombe-Terrier M-J, et al. 1993. Primitive malignant nonepithelial hepatic tumors in children. Med Pediatr Oncol 21:634–639.

    Article  PubMed  CAS  Google Scholar 

  57. Urban CE, Mache CJ, Schwinger W, et al. 1993. Undifferentiated (embryonal) sarcoma of the liver in childhood: successful combined-modality therapy in four patients. Cancer 72:2511–2516.

    Article  PubMed  CAS  Google Scholar 

  58. Walker NI, Horn MJ, Strong RW, et al. 1992. Undifferentiated (embryonal) sarcoma of the liver. Pathologic findings and long-term survival after complete surgical resection. Cancer 69:52–59.

    Article  PubMed  CAS  Google Scholar 

  59. Wu JT, Book L, Sudar K. 1981. Serum alpha fetoprotein levels in normal infants. Pediatr Res 15:50–52.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Science+Business Media New York

About this chapter

Cite this chapter

Douglass, E.C. (1997). Hepatic malignancies in childhood and adolescence (hepatoblastoma, hepatocellular carcinoma, and embryonal sarcoma). In: Walterhouse, D.O., Cohn, S.L. (eds) Diagnostic and Therapeutic Advances in Pediatric Oncology. Cancer Treatment and Research, vol 92. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5767-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-5767-8_7

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7643-9

  • Online ISBN: 978-1-4615-5767-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics